Global Health Limited (MEDANTA) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Global Health Limited stock ₹456, price ₹1,478, that is 69.2% below the price, quality 52 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Global Health Limited
MEDANTA · NSEFar too expensive (fair value 69% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 18, 2026.
How to read this chart
48‑month range ₹413.85 – ₹1,508.90 · fair‑value band ₹341.89 – ₹569.82 · the ₹1,478.30 price screens above the ₹455.86 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 18, 2026.
Every Wednesday you see whether Global Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Global Health Limited, together with its subsidiaries, provides healthcare services in India.
Show moreShow less
The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery.
It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup.
In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.
Stock analysis
Global Health Limited (MEDANTA) currently trades at ₹1,478.30, while our model-based Fair Value estimate is ₹455.86, 69% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹573.77 per share, and 0 of the 16 models we run sit above the ₹1,478.30 price.
Bear case: the Asset-Based group reads lowest at ₹98.43, and 16 of the 16 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹341.89 (bear) to ₹569.82 (bull), the price of ₹1,478.30 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Global Health Limited reported revenue of ₹44.1B in FY2026 versus ₹21.7B in FY2022, a compound +19.4%/yr. Reported net income was ₹5.6B in FY2026, compounding +29.8%/yr from FY2022.
Key figures
Market cap ₹398B (≈ $4.3B) Mid · P/E ratio 64.3 · P/S ratio 7.88 · EPS (TTM) ₹22.98 · Dividend yield 0.0% · Net margin 12.2% · Return on equity 15.2% · Return on assets (EBIT) 13.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 63 out of 100 (low confidence).
What moves the price
The share trades about 2% below its 52-week high and 54% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −69%, MEDANTA screens richer than that median.
Fair Value models
All 16 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
MEDANTA screens overvalued: fair value 69% below the price. Compare with HCA Healthcare, Inc →
Compare Global Health Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 249 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Dividend yield by industry
- EV/EBITDA by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $20.13 | $45.53 | +126% | vs MEDANTA |
| DaVita Inc DVA | $156.34 | $218.90 | +40% | vs MEDANTA |
| Aier Eye Hospital Group 300015 | ¥9.02 | ¥10.88 | +21% | vs MEDANTA |
| HCA Healthcare, Inc HCA | $460.33 | $547.34 | +19% | vs MEDANTA |
| Tenet Healthcare Corporation THC | $263.59 | $279.20 | +6% | vs MEDANTA |
| The Ensign Group ENSG | $176.59 | $140.09 | −21% | vs MEDANTA |
| Encompass Health Corporation EHC | $132.28 | $94.81 | −28% | vs MEDANTA |
| Fresenius SE FRE | €51.78 | €34.77 | −33% | vs MEDANTA |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | ﷼207.90 | ﷼109.45 | −47% | vs MEDANTA |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,738.00 | ₹2,907.70 | −67% | vs MEDANTA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Global Health Limited (MEDANTA) overvalued or undervalued?
What is the fair value of MEDANTA?
What is the quality score of MEDANTA?
What is the price target for Global Health Limited (MEDANTA)?
What is the Global Health Limited stock forecast for 2026?
What is the revenue of Global Health Limited (MEDANTA)?
Does Global Health Limited pay a dividend?
How much is the dividend of Global Health Limited (MEDANTA) and when is the ex-dividend date?
What is the intrinsic value of Global Health Limited (MEDANTA)?
Is Global Health Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MEDANTA?
How much is Global Health Limited worth?
What do the bullish and bearish scenarios say about MEDANTA?
What is the P/E ratio of MEDANTA?
How solid is the balance sheet of Global Health Limited (MEDANTA)?
How far is MEDANTA from its 52-week high?
Which stocks are comparable to Global Health Limited?
Is Global Health Limited stock attractive at the current price?
How is the fair value of MEDANTA calculated?
Is it still worth investing in stocks now?
What is the share price of Global Health Limited (MEDANTA)?
What should I pay attention to with Global Health Limited right now?
Key figures of Global Health Limited
How large is the market capitalisation of Global Health Limited (MEDANTA)?
What is the P/S ratio of Global Health Limited (MEDANTA)?
What are the earnings per share of Global Health Limited (MEDANTA)?
What is the dividend yield of Global Health Limited (MEDANTA)?
What is the net margin of Global Health Limited (MEDANTA)?
What is the return on equity of Global Health Limited (MEDANTA)?
What is the EBIT return on assets of Global Health Limited (MEDANTA)?
What is the operating margin of Global Health Limited (MEDANTA)?
How fast is revenue growing at Global Health Limited (MEDANTA)?
How fast are earnings growing at Global Health Limited (MEDANTA)?
How much free cash flow does Global Health Limited (MEDANTA) generate?
How much net debt does Global Health Limited (MEDANTA) carry?
Watch Global Health Limited in the live analysis
One click puts Global Health Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.